KVUE Kenvue Inc.
Consumer DefensiveAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
22.62
PEG
0.53
P/B
3.17
P/S
2.20
EV/EBITDA
12.66
DCF Value
$31.35
FCF Yield
5.4%
Div Yield
4.7%
Margins & Returns
Gross Margin
58.4%
Operating Margin
19.6%
Net Margin
10.6%
ROE
15.2%
ROA
6.0%
ROIC
9.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $3.91B | $474.0M | $— |
| Q4 null | $3.78B | $330.0M | $— |
| FY null | $15.12B | $1.47B | $— |
| Q3 null | $3.76B | $398.0M | $— |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$18.25
Target (Median)
$18.00
Target Range
$18.00 - $19.00
Trading Activity
Insider Trades
View AllCongress Trades
View AllRelated AI Research
Latest News
Company Info
Sector
Consumer Defensive
Industry
Household & Personal Products
Country
US
Exchange
—
Beta
0.52
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.